CD8A and prostate cancer: A study using TRAMP-C2 prostate cancer model demonstrated an increase of non-recirculating tumor-specific CD8+ T cells in non-lymphoid tissue (NLT) distal to the tumor after IRE treatment, specifically within the salivary gland, contralateral skin, and liver (167).